Nexien BioPharma, Inc (OTC: NXEN) Developing a cannabinoid-based drug pipeline.

November 14, 2018 admin CEO Interview, Healthcare Comments Off on Nexien BioPharma, Inc (OTC: NXEN) Developing a cannabinoid-based drug pipeline.
Alex Wasyl, CEO Nexien BioPharma

 

Discover Tomorrow’s Winning Stocks!
Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

 

 

Alex Wasyl, CEO Nexien BioPharma

 

 

 

 

 

 

Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.




Related Articles

CEO Interview

MYM Nutraceuticals, Inc. (OTC: MYMMF) Rob Gietl, CEO Interview. Medicinal cannabis company projects “$3 billion revenues in 2020”.

November 1, 2018 admin CEO Interview, Consumer Comments Off on MYM Nutraceuticals, Inc. (OTC: MYMMF) Rob Gietl, CEO Interview. Medicinal cannabis company projects “$3 billion revenues in 2020”.

  Discover Tomorrow’s Winning Stocks! Thank you for subscribing. Something went wrong. Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox. […]

CEO Interview

The Yield Growth Corp. (CSE: BOSS) (OTC: BOSQF) Hemp-infused beauty and wellness brands – expanding distribution with ipsy, launching in China.

June 12, 2019 admin CEO Interview, Consumer Comments Off on The Yield Growth Corp. (CSE: BOSS) (OTC: BOSQF) Hemp-infused beauty and wellness brands – expanding distribution with ipsy, launching in China.

  Discover Tomorrow’s Winning Stocks! Thank you for subscribing. Something went wrong. Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox. […]